Each manufacturer shall identify by suitable means the acceptance status of product, to indicate the conformance or nonconformance of product with acceptance criteria. The identification of acceptance status shall be maintained throughout manufacturing, packaging, labeling, installation, and servicing of the product to ensure that only product which has passed the required acceptance activities is distributed, used, or installed. Subpart I—Nonconforming Product
21 CFR Part 820 · Quality Management System Regulation
§ 820.86 Acceptance status
Independent copy, not an official legal edition. 21 CFR is a U.S. Government work in the public domain; this text comes from the eCFR and the annual CFR edition, and may lag recent amendments. The authoritative version is on ecfr.gov. Compliome is not affiliated with or endorsed by FDA. Not legal advice.
What FDA inspectors cite under § 820.86
Form FDA 483 observations citing this section, fiscal years 2009–2026 (Devices).
- Acceptance status 99
- Maintained 3
Warning letters citing § 820.86
8 FDA warning letters since 2017 cite this section :
- LEVO AG 18 Jul 2025
- DFI Co., Ltd. 6 May 2025
- Exer Labs, Inc. 10 Feb 2025
- Rolence Ent. Inc. 18 Oct 2024
- Ming Fai Industrial Co LTD 1 Jun 2023
- Wickimed Medical Equipment Manufacturing Co., Ltd. 7 Jan 2022
- Global Medical Production Co Ltd 16 Nov 2021
- Dongguan Microview Medical Technology Co., LTD 20 Sept 2019